Aldose reductase (AR) has been a long-standing target for treating diabetic complications, but its structural similarity to related enzymes has made selective inhibition difficult. Off-target binding ...
Recent advances in molecular mapping, atomic-resolution drug design, and a U.S. cannabis policy shift could accelerate biomedical research and improve drug safety. The new SEE-CITE probe and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results